v3.25.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-based Compensation [Abstract]  
Schedule of Binomial Option-Pricing Model Used for the Fair Value Measurement

The following table lists the inputs to the binomial option-pricing model used for the fair value measurement of equity-settled share options for the above Options Plans for the years 2024, 2023 and 2022:

 

   December 31, 
   2024   2023   2022 
             
Dividend yield   -%   0%   0%
Expected volatility of the share prices   -%   107%   84%
Risk-free interest rate   -%   4.2%   2.1%
Expected term (in years)   
-
    10%   10 

 

*During the year 2024 there were no new grants of options.
Schedule of Number of Options Granted to Employees Under the Option Plans The following table summarizes the number of options granted to employees under the Option Plans for the year ended December 31, 2024 and related information:
   Number of
options
   Weighted
average
exercise
price
   Weighted
average
remaining
contractual
term
(in years)
   Aggregate
intrinsic
value
 
                 
Balance as of December 31, 2023   98,491,200    0.005    9.9    12 
                     
Granted   
-
    
-
    
-
    
-
 
Forfeited   (1,262,800)   0.005    9.9    12 
                     
Balance as of December 31, 2024   97,228,400    0.005    8.65    12 
                     
Exercisable as of December 31, 2024   32,409,467    0.005    8.65    12 
Schedule of Company’s Outstanding and Exercisable Options Granted to Employees The following table summarizes information about the Company’s outstanding and exercisable options granted to employees as of December 31, 2024:
Exercise price   Options
outstanding
as of
December 31,
2024
   Weighted
average
remaining
contractual term
(years)
   Options
exercisable
as of
December 31,
2024
   Weighted
average
remaining
contractual
term
(years)
 
$0.005   97,228,400    8.65    32,409,467    8.65 
Schedule of ADSs Restricted Shares Units Activity A summary of ADSs restricted shares units activity for the year ended December 31, 2024 is as follows:
   Number of
ADS
   Weighted
average
grant date
fair value
 
         
Balance as of December 31, 2023   30,503    30.6 
           
Granted   94,964    4.46 
Vested   (15,893)   30.6 
Forfeited   (3,391)   30.6 
           
Balance as of December 31, 2024   106,183    7.22 
Schedule of Total Share-Based Compensation Expense to Equity-Based Awards
   Year ended December 31, 
   2024   2023   2022 
             
Research and development expenses  $322   $107   $100 
Marketing, general and administrative expenses   360    1,032    1,502 
Total share-based compensation  $682   $1,139   $1,602